
Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 25, 2020, titled "Zydus Cadila receives final approval from USFDA for Dimethyl Fumarate Delayed-Release Capsules".
Filed with NSE ·

Cadila Healthcare Limited has informed the Exchange regarding a press release dated September 25, 2020, titled "Zydus Cadila receives final approval from USFDA for Dimethyl Fumarate Delayed-Release Capsules".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences